Sulfate (SO(4)(2-)) is an important nutrient for human growth and development, and is obtained from the diet and the intra-cellular metabolism of
sulfur-containing
amino acids, including
methionine and
cysteine. During pregnancy, fetal tissues have a limited capacity to produce
sulfate, and rely on
sulfate obtained from the maternal circulation.
Sulfate enters and exits placental and fetal cells via transporters on the plasma membrane, which maintain a sufficient intracellular supply of
sulfate and its universal sulfonate donor 3'-phosphoadenosine 5'-phosphosulfate (PAPS) for
sulfate conjugation (sulfonation) reactions to function effectively.
Sulfotransferases mediate sulfonation of numerous endogenous compounds, including
proteins and
steroids, which biotransforms their
biological activities. In addition, sulfonation of
proteoglycans is important for maintaining normal structure and development of tissues, as shown for reduced sulfonation of cartilage
proteoglycans that leads to developmental
dwarfism disorders and four different
osteochondrodysplasias (
diastrophic dysplasia,
atelosteogenesis type II,
achondrogenesis type IB and
multiple epiphyseal dysplasia). The removal of
sulfate via
sulfatases is an important step in
proteoglycan degradation, and defects in several
sulfatases are linked to perturbed fetal bone development, including
mesomelia-synostoses syndrome and
chondrodysplasia punctata 1. In recent years, interest in
sulfate and its role in developmental biology has expanded following the characterisation of
sulfate transporters,
sulfotransferases and
sulfatases and their involvement in fetal growth. This review will focus on the physiological roles of
sulfate in fetal development, with links to human and animal pathophysiologies.